The effect of Taohong Siwu decoction combined with antihypertensive medicine in the treatment of hypertension: Meta-analysis

Author:

Xie Peng-Cheng1ORCID,Liang Qiu-Er1,Tu Wan-Qing1,Xie Ting1,Lam Lai Kwan1ORCID,Chen Li-Guo1

Affiliation:

1. School of Traditional Chinese Medicine of Jinan University, Guangzhou, China.

Abstract

Background: Taohong Siwu Decoction (THSWD) is a classic prescription of traditional Chinese medicine. Recent research has shown that the practical components of THSWD have specific curative effects on various cardiovascular diseases, including hypertension, suggesting THSWD could effectively lower blood pressure (BP) with fewer side effects. However, little information is available regarding the effectiveness of THSWD combined with antihypertensive medicine on hypertension. Objective: This meta-analysis aimed to study the efficacy and safety of THSWD in treating hypertension. Methods: According to the search strategy, 8 databases were searched, including China Knowledge Network (CNKI), Wanfang Database, VIP Database, Pubmed, China Biomedical Literature Database (CBM), web of science, EMBASE and Cochrane Library, for the randomized controlled trial of THSWD on hypertension. 9 RCTs were included and 827 patients were involved. This meta-analysis used RevMan 5.4 to evaluate the articles. Results: This review included 9 RCTs. All studies were THSWD with the antihypertensive drug compared with single antihypertensive western medicine. The total effective rate of THSWD combined with corresponding western medicine was significantly improved (Relative risk = 1.26; 95% CI: 1.16–1.37, P < .00001), which could effectively reduce the systolic BP (MD = −15.28 mm Hg; 95% CI: −20.17 to −10.40, P < .00001=, diastolic BP (MD = −9.70 mm Hg; 95% CI: −12.66 to −6.73, P < .00001), Triglycerides (MD = −1.48, 95%CI: −2.09 to −0.87, P < .00001), total cholesterol (MD = −1.43, 95% CI: −1.63 to −1.24, P < .00001) and low density lipoprotein cholesterol (MD = −0.93, 95% CI: −1.07 to −0.80, P < .00001). Compared with the single routine western medicine group, THSWD combined with the corresponding western medicine increased serum high-density lipoprotein (MD = 0.41, 95% CI: 0.35 to 0.46, P < .00001). Conclusion: THSWD combined with antihypertensive drugs in treating hypertension was curative in lowering BP, improving blood lipid levels and reducing the incidence of adverse reactions compared to antihypertensive medications treatment. However, more high-quality studies are needed due to the biased results and the small number of studies for further verification of the effectiveness of THSWD, and providing a new treatment for clinical reference.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference34 articles.

1. Status of hypertension in China: results from the China hypertension survey, 2012-2015.;Wang;Circulation,2018

2. 2019 Chinese guidelines for the management of hypertension in the elderly.;Li;Chin J Geriatr Res,2019

3. Analysis of common adverse drug reactions in hypertension.;Chen;China Pract Med,2021

4. Interpretation of expert consensus on diagnosis and treatment of hypertension with traditional Chinese medicine.;Meng;Chin J Exp Tradit Med Formulae,2022

5. Time-dose effects of Taohong Siwu decoction on number and funcitional activity of peripheral blood endothelial progenitor cells.;Wang;Chin J Tissue Eng Res,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3